Press Releases
Bioneer Successfully Concludes Participation in ‘EADV 2024’
관리자 / 2024-12-31
Bioneer Successfully Concludes Participation in ‘EADV 2024’
-The
clinic-exclusive product CosmeRNA Intensive unveiled for the first time
-Consultations
held with leading global hair specialists and professional companies at the
promotional booth
-Innovative
hair loss solutions showcased at EADV 2024
Bioneer
announced on the 30th that it had successfully concluded its participation in
the 2024 EADV (European Academy of Dermatology and Venereology) held from
September 25 to 28 in Amsterdam, Netherlands. The company showcased its
innovative hair loss cosmetic product, CosmeRNA, and its hair loss molecular
diagnostic kit, attracting significant attention.
The
33rd EADV annual meeting is Europe’s largest event where global pharmaceutical
companies and dermatologists gather to share the latest research and
technologies. This year marked Bioneer’s second participation in the event,
aiming to promote CosmeRNA to hair loss specialists and establish business
partnerships.
At the
exhibition, Bioneer unveiled CosmeRNA Intensive, a clinic-exclusive
product, for the first time. The product garnered high interest from dermatologists
and distribution partners, leading to numerous inquiries and pre-orders.
Bioneer
also conducted live demonstrations using its IRON-qPCR™ molecular diagnostic
device, which was developed over a decade. By analyzing a single hair strand,
the device can quantify the expression of hair loss-related mRNA within 40
minutes, making it the first of its kind to offer molecular diagnostics for
hair loss. Dermatology specialists expressed amazement at the innovation and
showed interest in incorporating the technology into their clinics.
The
company highlighted its development of CosmeRNA ARI, which reduces the mRNA
expression of androgen receptors in hair follicles. This product won the Hair
Product of the Year award at the Cosmoprof Awards 2024, the world’s
largest cosmetics exhibition, where it demonstrated an 80–90% response rate for
androgenic alopecia. It is now being sold globally as one of the most
innovative cosmetics.
Hair
loss can result from various causes beyond androgen factors, leading to diverse
mRNA changes in hair follicle cells. Bioneer’s ability to quantify hair
loss-related mRNA in 40 minutes offers the potential to standardize molecular
diagnostics for hair loss in global clinics.
Looking
ahead, Bioneer plans to develop a portfolio of CosmeRNA products targeting
major hair loss-related mRNAs while supplying diagnostic equipment to global
markets. By integrating molecular diagnostics with customized cosmetics
targeting hair loss-inducing mRNA, the company aims to pioneer a new paradigm
for hair loss management. This innovative approach has garnered significant
praise from specialists worldwide.
A
company representative stated, “With CosmeRNA’s proven safety and convenience,
we are working with global dermatologists, professors, and experts to establish
a new paradigm in hair loss molecular diagnostics and personalized management.
Following connections made at this event, we plan to expand international sales
channels and focus on advancing on-site molecular diagnostics and CosmeRNA
products addressing diverse hair loss causes.”